Ondine Biomedical Inc. OBIMF

Company Overview

Ondine Biomedical Inc. is a clinical-stage life sciences company focused on the prevention and treatment of infectious diseases using non-antibiotic technologies. The company operates within the medical devices and biopharmaceutical industries, with a primary emphasis on infection prevention in healthcare settings. Its core commercial and development activities center on photodisinfection therapies designed to reduce harmful pathogens without contributing to antimicrobial resistance.

The company’s primary revenue driver is its proprietary nasal photodisinfection platform, marketed under the Steriwave brand, which is designed to rapidly reduce pathogen load in the nasal passages, including bacteria and certain viruses. Ondine’s strategic positioning is based on addressing a critical global healthcare challenge—hospital-acquired infections—through a technology that is positioned as a complement or alternative to antibiotics. Ondine Biomedical Inc. was founded in Canada and has evolved from early-stage research into a company with regulatory-cleared products in select international markets, particularly in Europe.